|
Exhibit 10.1
UNITED STATES DEPARTMENT OF THE TREASURY
1500 PENNSYLVANIA AVENUE, NW
WASHINGTON, D.C. 20220
Dear Ladies and Gentlemen:
The company set forth on the signature page hereto (the "
Company ") intends to issue in a private placement the
number of shares of a series of its preferred stock set forth on
Schedule A hereto (the " Preferred Shares ") and a warrant
to purchase the number of shares of its common stock set forth on
Schedule A hereto (the " Warrant " and, together with the
Preferred Shares, the " Purchased Securities ") and the
United States Department of the Treasury (the " Investor ")
intends to purchase from the Company the Purchased Securities.
The purpose of this letter agreement is to confirm the terms and
conditions of the purchase by the Investor of the Purchased
Securities. Except to the extent supplemented or superseded by the
terms set forth herein or in the Schedules hereto, the provisions
contained in the Securities Purchase Agreement – Standard
Terms attached hereto as Exhibit A (the " Securities Purchase
Agreement ") are incorporated by reference herein. Terms that
are defined in the Securities Purchase Agreement are used in this
letter agreement as so defined. In the event of any inconsistency
between this letter agreement and the Securities Purchase
Agreement, the terms of this letter agreement shall govern.
Each of the Company and the Investor hereby confirms its
agreement with the other party with respect to the issuance by the
Company of the Purchased Securities and the purchase by the
Investor of the Purchased Securities pursuant to this letter
agreement and the Securities Purchase Agreement on the terms
specified on Schedule A hereto.
This letter agreement (including the Schedules hereto) and the
Securities Purchase Agreement (including the Annexes thereto) and
the Warrant constitute the entire agreement, and supersede all
other prior agreements, understandings, representations and
warranties, both written and oral, between the parties, with
respect to the subject matter hereof. This letter agreement
constitutes the "Letter Agreement" referred to in the Securities
Purchase Agreement.
This letter agreement may be executed in any number of separate
counterparts, each such counterpart being deemed to be an original
instrument, and all such counterparts will together constitute the
same agreement. Executed signature pages to this letter agreement
may be delivered by facsimile and such facsimiles will be deemed as
sufficient as if actual signature pages had been delivered.
* * *
In witness whereof, this letter agreement has been duly executed
and delivered by the duly authorized representatives of the parties
hereto as of the date written below.
UNITED STATES DEPARTMENT OF THE TREASURY
By:__________________________________
Name:
Title:
COMPANY:
BANCORP RHODE ISLAND, INC.
By___________________________________
Name: Merrill W. Sherman
Title: President & CEO
Date: December 19, 2008
EXHIBIT A
SECURITIES PURCHASE AGREEMENT
STANDARD TERMS
TABLE OF CONTENTS
Page
Article I
Purchase; Closing
Article II
Representations and Warranties
|
2.2
|
Representations and Warranties of the
Company
|
5
|
Article III
Covenants
|
3.1
|
Commercially Reasonable Efforts
|
13
|
|
3.3
|
Sufficiency of Authorized Common Stock; Exchange
Listing
|
14
|
|
3.4
|
Certain Notifications Until Closing
|
15
|
|
3.5
|
Access, Information and
Confidentiality
|
15
|
Article IV
Additional Agreements
|
4.1
|
Purchase for Investment
|
16
|
|
4.3
|
Certain Transactions
|
18
|
|
4.4
|
Transfer of Purchased Securities and Warrant
Shares; Restrictions on Exercise of
|
|
4.5
|
Registration Rights
|
19
|
|
4.6
|
Voting of Warrant Shares
|
30
|
|
4.8
|
Restriction on Dividends and
Repurchases
|
31
|
|
4.9
|
Repurchase of Investor Securities
|
32
|
|
4.10
|
Executive Compensation
|
33
|
Article V
Miscellaneous
|
5.2
|
Survival of Representations and
Warranties
|
34
|
|
5 .4
|
Waiver of Conditions
|
34
|
|
5.5
|
Governing Law: Submission to Jurisdiction,
Etc.
|
35
|
|
5.10
|
No Third Part Beneficiaries
|
36
|
LIST OF ANNEXES
ANNEX A: FORM OF CERTIFICATE OF DESIGNATIONS FOR PREFERRED
STOCK
ANNEX B: FORM OF WAIVER
ANNEX C: FORM OF OPINION
ANNEX D: FORM OF WARRANT
INDEX OF DEFINED TERMS
|
Term
|
Location of Definition
|
|
Affiliate
|
5. 7(b)
|
|
Agreement
|
Recitals
|
|
Appraisal Procedure
|
4.9(c)(i)
|
|
Appropriate Federal Banking Agency
|
2.2(s)
|
|
Bankruptcy Exceptions
|
2.2(d)
|
|
Benefit Plans
|
1.2(d)(iv)
|
|
Board of Directors
|
2.2(f)
|
|
Business Combination
|
4.4
|
|
business day
|
1.3
|
|
Capitalization Date
|
2.2(b)
|
|
Certificate of Designations
|
i.2( d)(iii)
|
|
Charter
|
i.2( d)(iii)
|
|
Closing
|
i.2(a)
|
|
Closing Date
|
1.2(a)
|
|
Code
|
2.2(n)
|
|
Common Stock
|
Recitals
|
|
Company
|
Recitals
|
|
Company Financial Statements
|
2.2(h)
|
|
Company Material Adverse Effect
|
2.1(a)
|
|
Company Reports
|
2.2(i)(i)
|
|
Company Subsidiary; Company
Subsidiaries
|
2.2(i)(i)
|
|
control; controlled by; under common control
with
|
5.7(b)
|
|
Controlled Group
|
2.2(n)
|
|
CPP
|
Recitals
|
|
EESA
|
1.2(d)(iv)
|
|
ERISA
|
2.2(n)
|
|
Exchange Act
|
2.1(b)
|
|
Fair Market Value
|
4.9(c)(ii)
|
|
GAAP
|
2.I(a)
|
|
Governmental Entities
|
1.2(c)
|
|
Holder
|
4.5(k)(i)
|
|
Holders’ Counsel
|
4.5(k)(ii)
|
|
Indemnitee
|
4.5(g)(i)
|
|
Information
|
3.5(b)
|
|
Initial Warrant Shares
|
Recitals
|
|
Investor
|
Recitals
|
|
Junior Stock
|
4.8(c)
|
|
knowledge of the Company; Company’s
knowledge
|
5.7(c)
|
|
Last Fiscal Year
|
2.1(b)
|
|
Letter Agreement
|
Recitals
|
|
officers
|
5.7(c)
|
|
Parity Stock
|
4.8(c)
|
|
Pending Underwritten Offering
|
4.5(1)
|
|
Permitted Repurchases
|
4.8(a)(ii)
|
|
Piggyback Registration
|
4.5(a)(iv)
|
|
Plan
|
2.2(n)
|
|
Preferred Shares
|
Recitals
|
|
Preferred Stock
|
Recitals
|
|
Previously Disclosed
|
2.1(b)
|
|
Proprietary Rights
|
2.2(u)
|
|
Purchase
|
Recitals
|
|
Purchase Price
|
1.1
|
|
Purchased Securities
|
Recitals
|
|
Qualified Equity Offering
|
4.4
|
|
register; registered; registration
|
4.5(k)(iii)
|
|
Registrable Securities
|
4.5(k)(iv)
|
|
Registration Expenses
|
4.5(k)(v)
|
|
Regulatory Agreement
|
2.2(s)
|
|
Rule 144; Rule 144A; Rule 159A; Rule 405; Rule
415
|
4.5(k)(vi)
|
|
Schedules
|
Recitals
|
|
SEC
|
2.1(b)
|
|
Securities Act
|
2.2(a)
|
|
Selling Expenses
|
4.5(k)(vii)
|
|
Senior Executive Officers
|
4.10
|
|
Share Dilution Amount
|
4.8(a)(ii)
|
|
Shelf Registration Statement
|
4.5(a)(ii)
|
|
Signing Date
|
2.1(a)
|
|
Special Registration
|
4.5(i)
|
|
Stockholder Proposals
|
3.1(b)
|
|
subsidiary
|
5.8(a)
|
|
Tax; Taxes
|
2.2(0)
|
|
Transfer
|
4.4
|
|
Warrant
|
Recitals
|
|
Warrant Shares
|
2.2(d)
|
SECURITIES PURCHASE AGREEMENT — STANDARD TERMS
Recitals:
WHEREAS, the United States Department of the Treasury (the
"Investor") may from time to time agree to purchase shares
of preferred stock and warrants from eligible financial
institutions which elect to participate in the Troubled Asset
Relief Program Capital Purchase Program ("CPP");
WHEREAS, an eligible financial institution electing to
participate in the CPP and issue securities to the Investor
(referred to herein as the "Company") shall enter into a
letter agreement (the "Letter Agreement") with the Investor
which incorporates this Securities Purchase Agreement —
Standard Terms;
WHEREAS, the Company agrees to expand the flow of credit to U.S.
consumers and businesses on competitive terms to promote the
sustained growth and vitality of the U.S. economy;
WHEREAS, the Company agrees to work diligently, under existing
programs, to modify the terms of residential mortgages as
appropriate to strengthen the health of the U.S. housing
market;
WHEREAS, the Company intends to issue in a private placement the
number of shares of the series of its Preferred Stock
("Preferred Stock") set forth on Schedule A to the
Letter Agreement (the "Preferred Shares") and a warrant to
purchase the number of shares of its Common Stock ("Common
Stock") set forth on Schedule A to the Letter Agreement
(the "Initial Warrant Shares") (the "Warrant" and, together
with the Preferred Shares, the "Purchased Securities") and
the Investor intends to purchase (the "Purchase") from the
Company the Purchased Securities; and
WHEREAS, the Purchase will be governed by this Securities
Purchase Agreement —Standard Terms and the Letter Agreement,
including the schedules thereto (the "Schedules"),
specifying additional terms of the Purchase. This Securities
Purchase Agreement — Standard Terms (including the Annexes
hereto) and the Letter Agreement (including the Schedules thereto)
are together referred to as this "Agreement". All references in
this Securities Purchase Agreement — Standard Terms to
"Schedules" are to the Schedules attached to the Letter
Agreement.
NOW, THEREFORE, in consideration of the premises, and of
the representations, warranties, covenants and agreements set forth
herein, the parties agree as follows:
Article I
Purchase; Closing
1.1 Purchase .
On the terms and subject to the conditions set forth in this
Agreement, the Company agrees to sell to the Investor, and the
Investor agrees to purchase from the Company, at the Closing (as
hereinafter defined), the Purchased Securities for the price set
forth on Schedule A (the "Purchase Price").
(a) On the terms and
subject to the conditions set forth in this Agreement, the closing
of the Purchase (the "Closing") will take place at the
location specified in Schedule A , at the time and on the
date set forth in Schedule A or as soon as practicable
thereafter, or at such other place, time and date as shall be
agreed between the Company and the Investor. The time and date on
which the Closing occurs is referred to in this Agreement as the
"Closing Date".
(b) Subject to the
fulfillment or waiver of the conditions to the Closing in this
Section 1.2, at the Closing the Company will deliver the Preferred
Shares and the Warrant, in each case as evidenced by one or more
certificates dated the Closing Date and bearing appropriate legends
as hereinafter provided for, in exchange for payment in full of the
Purchase Price by wire transfer of immediately available United
States funds to a bank account designated by the Company on
Schedule A .
(c) The respective
obligations of each of the Investor and the Company to consummate
the Purchase are subject to the fulfillment (or waiver by the
Investor and the Company, as applicable) prior to the Closing of
the conditions that (i) any approvals or authorizations of all
United States and other governmental, regulatory or judicial
authorities (collectively, "Governmental Entities") required
for the consummation of the Purchase shall have been obtained or
made in form and substance reasonably satisfactory to each party
and shall be in full force and effect and all waiting periods
required by United States and other applicable law, if any, shall
have expired and (ii) no provision of any applicable United States
or other law and no judgment, injunction, order or decree of any
Governmental Entity shall prohibit the purchase and sale of the
Purchased Securities as contemplated by this Agreement.
(d) The obligation of
the Investor to consummate the Purchase is also subject to the
fulfillment (or waiver by the Investor) at or prior to the Closing
of each of the following conditions:
(i) (A) the
representations and warranties of the Company set forth in (x)
Section 2.2(g) of this Agreement shall be true and correct in all
respects as though made on and as of the Closing Date, (y) Sections
2.2(a) through (f) shall be true and correct in all material
respects as though made on and as of the Closing Date (other than
representations and warranties that by their terms speak as of
another date, which representations and warranties shall be true
and correct in all material respects as of such other date) and (z)
Sections 2.2(h) through (v) (disregarding all qualifications or
limitations set forth in such representations and warranties as to
"materiality", "Company
Material Adverse Effect" and words of similar import) shall be
true and correct as though made on and as of the Closing Date
(other than representations and warranties that by their terms
speak as of another date, which representations and warranties
shall be true and correct as of such other date), except to the
extent that the failure of such representations and warranties
referred to in this Section 1.2(d)(i)(A)(z) to be so true and
correct, individually or in the aggregate, does not have and would
not reasonably be expected to have a Company Material Adverse
Effect and (B) the Company shall have performed in all material
respects all obligations required to be performed by it under this
Agreement at or prior to the Closing;
(ii) the Investor shall
have received a certificate signed on behalf of the Company by a
senior executive officer certifying to the effect that the
conditions set forth in Section 1.2(d)(i) have been satisfied;
(iii) the Company shall have
duly adopted and filed with the Secretary of State of its
jurisdiction of organization or other applicable Governmental
Entity the amendment to its certificate or articles of
incorporation, articles of association, or similar organizational
document ("Charter") in substantially the form attached
hereto as Annex A (the "Certificate of Designations")
and such filing shall have been accepted;
(iv) (A) the Company shall
have effected such changes to its compensation, bonus, incentive
and other benefit plans, arrangements and agreements (including
golden parachute, severance and employment agreements)
(collectively, "Benefit Plans") with respect to its Senior
Executive Officers (and to the extent necessary for such changes to
be legally enforceable, each of its Senior Executive Officers shall
have duly consented in writing to such changes), as may be
necessary, during the period that the Investor owns any debt or
equity securities of the Company acquired pursuant to this
Agreement or the Warrant, in order to comply with Section 111(b) of
the Emergency Economic Stabilization Act of 2008 ("EESA") as
implemented by guidance or regulation thereunder that has been
issued and is in effect as of the Closing Date, and (B) the
Investor shall have received a certificate signed on behalf of the
Company by a senior executive officer certifying to the effect that
the condition set forth in Section 1.2(d)(iv)(A) has been
satisfied;
(v) each of the
Company’s Senior Executive Officers shall have delivered to
the Investor a written waiver in the form attached hereto as
Annex B releasing the Investor from any claims that such
Senior Executive Officers may otherwise have as a result of the
issuance, on or prior to the Closing Date, of any regulations which
require the modification of, and the agreement of the Company
hereunder to modify, the terms of any Benefit Plans with respect to
its Senior Executive Officers to eliminate any provisions of such
Benefit Plans that would not be in compliance with the requirements
of Section 111(b) of the EESA as implemented by guidance or
regulation thereunder that has been issued and is in effect as of
the Closing Date;
(vi) the Company shall have
delivered to the Investor a written opinion from counsel to the
Company (which may be internal counsel), addressed to the Investor
and dated as of the Closing Date, in substantially the form
attached hereto as Annex C;
(vii) the Company shall have
delivered certificates in proper form or, with the prior consent of
the Investor, evidence of shares in book-entry form, evidencing the
Preferred Shares to Investor or its designee(s); and (viii) the
Company shall have duly executed the Warrant in substantially the
form attached hereto as Annex D and delivered such executed
Warrant to the Investor or its designee(s).
1.3
Interpretation. When a reference is made in this Agreement
to "Recitals," "Articles," "Sections," or "Annexes" such reference
shall be to a Recital, Article or Section of, or Annex to, this
Securities Purchase Agreement – Standard Terms, and a
reference to "Schedules" shall be to a Schedule to the Letter
Agreement, in each case, unless otherwise indicated. The terms
defined in the singular have a comparable meaning when used in the
plural, and vice versa. References to "herein", "hereof",
"hereunder" and the like refer to this Agreement as a whole and not
to any particular section or provision, unless the context requires
otherwise. The table of contents and headings contained in this
Agreement are for reference purposes only and are not part of this
Agreement. Whenever the words "include," "includes" or "including"
are used in this Agreement, they shall be deemed followed by the
words "without limitation." No rule of construction against the
draftsperson shall be applied in connection with the interpretation
or enforcement of this Agreement, as this Agreement is the product
of negotiation between sophisticated parties advised by counsel.
All references to "$" or "dollars" mean the lawful currency of the
United States of America. Except as expressly stated in this
Agreement, all references to any statute, rule or regulation are to
the statute, rule or regulation as amended, modified, supplemented
or replaced from time to time (and, in the case of statutes,
include any rules and regulations promulgated under the statute)
and to any section of any statute, rule or regulation include any
successor to the section. References to a "business day"
shall mean any day except Saturday, Sunday and any day on which
banking institutions in the State of New York generally are
authorized or required by law or other governmental actions to
close.
Article II
Representations and Warranties
(a) "Company
Material Adverse Effect" means a material adverse effect on (i)
the business, results of operation or financial condition of the
Company and its consolidated subsidiaries taken as a whole;
provided, however, that Company Material Adverse Effect
shall not be deemed to include the effects of (A) changes after the
date of the Letter Agreement (the "Signing Date") in general
business, economic or market conditions (including changes
generally in prevailing interest rates, credit availability and
liquidity, currency exchange rates and price levels or trading
volumes in the United States or foreign securities or credit
markets), or any outbreak or escalation of hostilities, declared or
undeclared acts of war or terrorism, in each case generally
affecting the industries in which the Company and its
subsidiaries operate, (B) changes or proposed changes after the
Signing Date in generally accepted accounting principles in the
United States ("GAAP") or regulatory accounting
requirements, or authoritative interpretations thereof, (C) changes
or proposed changes after the Signing Date in securities, banking
and other laws of general applicability or related policies or
interpretations of Governmental Entities (in the case of each of
these clauses (A), (B) and (C), other than changes or occurrences
to the extent that such changes or occurrences have or would
reasonably be expected to have a materially disproportionate
adverse effect on the Company and its consolidated subsidiaries
taken as a whole relative to comparable U.S. banking or financial
services organizations), or (D) changes in the market price or
trading volume of the Common Stock or any other equity,
equity-related or debt securities of the Company or its
consolidated subsidiaries (it being understood and agreed that the
exception set forth in this clause (D) does not apply to the
underlying reason giving rise to or contributing to any such
change); or (ii) the ability of the Company to consummate the
Purchase and the other transactions contemplated by this Agreement
and the Warrant and perform its obligations hereunder or thereunder
on a timely basis.
(b) "Previously
Disclosed" means information set forth or incorporated in the
Company’s Annual Report on Form 10-K for the most recently
completed fiscal year of the Company filed with the Securities and
Exchange Commission (the "SEC’) prior to the Signing
Date (the "Last Fiscal Year") or in its other reports and
forms filed with or furnished to the SEC under Sections 13(a),
14(a) or 15(d) of the Securities Exchange Act of 1934 (the
"Exchange Act") on or after the last day of the Last Fiscal
Year and prior to the Signing Date.
2.2 Representations
and Warranties of the Company. Except as Previously Disclosed,
the Company represents and warrants to the Investor that as of the
Signing Date and as of the Closing Date (or such other date
specified herein):
(a) Organization,
Authority and Significant Subsidiaries. The Company has been
duly incorporated and is validly existing and in good standing
under the laws of its jurisdiction of organization, with the
necessary power and authority to own its properties and conduct its
business in all material respects as currently conducted, and
except as has not, individually or in the aggregate, had and would
not reasonably be expected to have a Company Material Adverse
Effect, has been duly qualified as a foreign corporation for the
transaction of business and is in good standing under the laws of
each other jurisdiction in which it owns or leases properties or
conducts any business so as to require such qualification; each
subsidiary of the Company that is a "significant subsidiary" within
the meaning of Rule 1-02(w) of Regulation S-X under the Securities
Act of 1933 (the "Securities Act") has been duly organized
and is validly existing in good standing under the laws of its
jurisdiction of organization. The Charter and bylaws of the
Company, copies of which have been provided to the Investor prior
to the Signing Date, are true, complete and correct copies of such
documents as in full force and effect as of the Signing Date.
(b)
Capitalization . The authorized capital stock of the
Company, and the outstanding capital stock of the Company
(including securities convertible into, or exercisable or
exchangeable for, capital stock of the Company) as of the most
recent fiscal month-end preceding the Signing Date (the
"Capitalization Date") is set forth on Schedule B .
The outstanding shares of capital stock of the Company have been
duly authorized and are validly
issued and outstanding, fully paid and nonassessable, and
subject to no preemptive rights (and were not issued in violation
of any preemptive rights). Except as provided in the Warrant, as of
the Signing Date, the Company does not have outstanding any
securities or other obligations providing the holder the right to
acquire Common Stock that is not reserved for issuance as specified
on Schedule B , and the Company has not made any other
commitment to authorize, issue or sell any Common Stock. Since the
Capitalization Date, the Company has not issued any shares of
Common Stock, other than (i) shares issued upon the exercise of
stock options or delivered under other equity-based awards or other
convertible securities or warrants which were issued and
outstanding on the Capitalization Date and disclosed on Schedule
B and (ii) shares disclosed on Schedule B .
(c) Preferred
Shares . The Preferred Shares have been duly and validly
authorized, and, when issued and delivered pursuant to this
Agreement, such Preferred Shares will be duly and validly issued
and fully paid and non-assessable, will not be issued in violation
of any preemptive rights, and will rank part passu with or
senior to all other series or classes of Preferred Stock, whether
or not issued or outstanding, with respect to the payment of
dividends and the distribution of assets in the event of any
dissolution, liquidation or winding up of the Company.
(d) The Warrant and
Warrant Shares . The Warrant has been duly authorized and, when
executed and delivered as contemplated hereby, will constitute a
valid and legally binding obligation of the Company enforceable
against the Company in accordance with its terms, except as the
same may be limited by applicable bankruptcy, insolvency,
reorganization, moratorium or similar laws affecting the
enforcement of creditors’ rights generally and general
equitable principles, regardless of whether such enforceability is
considered in a proceeding at law or in equity ("Bankruptcy
Exceptions"). The shares of Common Stock issuable upon exercise
of the Warrant (the "Warrant Shares") have been duly
authorized and reserved for issuance upon exercise of the Warrant
and when so issued in accordance with the terms of the Warrant will
be validly issued, fully paid and non-assessable, subject, if
applicable, to the approvals of its stockholders set forth on
Schedule C .
|
|
(e)
|
Authorization, Enforceability .
|
(i) The Company
has the corporate power and authority to execute and deliver this
Agreement and the Warrant and, subject, if applicable, to the
approvals of its stockholders set forth on Schedule C , to
carry out its obligations hereunder and thereunder (which includes
the issuance of the Preferred Shares, Warrant and Warrant Shares).
The execution, delivery and performance by the Company of this
Agreement and the Warrant and the consummation of the transactions
contemplated hereby and thereby have been duly authorized by all
necessary corporate action on the part of the Company and its
stockholders, and no further approval or authorization is required
on the part of the Company, subject, in each case, if applicable,
to the approvals of its stockholders set forth on Schedule C
. This Agreement is a valid and binding obligation of the Company
enforceable against the Company in accordance with its terms,
subject to the Bankruptcy Exceptions.
(ii) The execution,
delivery and performance by the Company of this Agreement and the
Warrant and the consummation of the transactions contemplated
hereby and thereby and compliance by the Company with the
provisions hereof and thereof, will not (A) violate, conflict with,
or result in a breach of any provision of, or constitute a default
(or an event which, with notice or lapse of time or both, would
constitute a default) under, or result in the termination of, or
accelerate the performance required by, or result in a right of
termination or acceleration of, or result in the creation of, any
lien, security interest, charge or encumbrance upon any of the
properties or assets of the Company or any Company Subsidiary under
any of the terms, conditions or provisions of (i) subject, if
applicable, to the approvals of the Company’s stockholders
set forth on Schedule C , its organizational documents or
(ii) any note, bond, mortgage, indenture, deed of trust, license,
lease, agreement or other instrument or obligation to which the
Company or any Company Subsidiary is a party or by which it or any
Company Subsidiary may be bound, or to which the Company or any
Company Subsidiary or any of the properties or assets of the
Company or any Company Subsidiary may be subject, or (B) subject to
compliance with the statutes and regulations referred to in the
next paragraph, violate any statute, rule or regulation or any
judgment, ruling, order, writ, injunction or decree applicable to
the Company or any Company Subsidiary or any of their respective
properties or assets except, in the case of clauses (A)(ii) and
(B), for those occurrences that, individually or in the aggregate,
have not had and would not reasonably be expected to have a Company
Material Adverse Effect.
(iii) Other than the filing
of the Certificate of Designations with the Secretary of State of
its jurisdiction of organization or other applicable Governmental
Entity, any current report on Form 8-K required to be filed with
the SEC, such filings and approvals as are required to be made or
obtained under any state "blue sky" laws, the filing of any proxy
statement contemplated by Section 3.1 and such as have been made or
obtained, no notice to, filing with, exemption or review by, or
authorization, consent or approval of, any Governmental Entity is
required to be made or obtained by the Company in connection with
the consummation by the Company of the Purchase except for any such
notices, filings, exemptions, reviews, authorizations, consents and
approvals the failure of which to make or obtain would not,
individually or in the aggregate, reasonably be expected to have a
Company Material Adverse Effect.
(f)
Anti-takeover Provisions and Rights Plan . The Board of
Directors of the Company (the "Board of Directors") has
taken all necessary action to ensure that the transactions
contemplated by this Agreement and the Warrant and the consummation
of the transactions contemplated hereby and thereby, including the
exercise of the Warrant in accordance with its terms, will be
exempt from any anti-takeover or similar provisions of the
Company’s Charter and bylaws, and any other provisions of any
applicable "moratorium", "control share", "fair price", "interested
stockholder" or other anti-takeover laws and regulations of any
jurisdiction. The Company has taken all actions necessary to render
any stockholders’ rights plan of the Company inapplicable to
this Agreement and the Warrant and the consummation of the
transactions contemplated hereby and thereby, including the
exercise of the Warrant by the Investor in accordance with its
terms.
(g) No Company
Material Adverse Effect . Since the last day of the last
completed fiscal period for which the Company has filed a Quarterly
Report on Form 10-Q or an Annual Report on Form 10-K with the SEC
prior to the Signing Date, no fact, circumstance, event, change,
occurrence, condition or development has occurred that,
individually or in the aggregate, has had or would reasonably be
expected to have a Company Material Adverse Effect.
(h) Company
Financial Statements . Each of the consolidated financial
statements of the Company and its consolidated subsidiaries
(collectively the "Company Financial Statements") included
or incorporated by reference in the Company Reports filed with the
SEC since December 31, 2006, present fairly in all material
respects the consolidated financial position of the Company and its
consolidated subsidiaries as of the dates indicated therein (or if
amended prior to the Signing Date, as of the date of such
amendment) and the consolidated results of their operations for the
periods specified therein; and except as stated therein, such
financial statements (A) were prepared in conformity with GAAP
applied on a consistent basis (except as may be noted therein), (B)
have been prepared from, and are in accordance with, the books and
records of the Company and the Company Subsidiaries and (C)
complied as to form, as of their respective dates of filing with
the SEC, in all material respects with the applicable accounting
requirements and with the published rules and regulations of the
SEC with respect thereto.
(i) Since
December 31, 2006, the Company and each subsidiary of the Company
(each a "Company Subsidiary" and, collectively, the
"Company Subsidiaries") has timely filed all reports,
registrations, documents, filings, statements and submissions,
together with any amendments thereto, that it was required to file
with any Governmental Entity (the foregoing, collectively, the
"Company Reports") and has paid all fees and assessments due
and payable in connection therewith, except, in each case, as would
not, individually or in the aggregate, reasonably be expected to
have a Company Material Adverse Effect. As of their respective
dates of filing, the Company Reports complied in all material
respects with all statutes and applicable rules and regulations of
the applicable Governmental Entities. In the case of each such
Company Report filed with or furnished to the SEC, such Company
Report (A) did not, as of its date or if amended prior to the
Signing Date, as of the date of such amendment, contain an untrue
statement of a material fact or omit to state a material fact
necessary in order to make the statements made therein, in light of
the circumstances under which they were made, not misleading, and
(B) complied as to form in all material respects with the
applicable requirements of the Securities Act and the Exchange Act.
With respect to all other Company Reports, the Company Reports were
complete and accurate in all material respects as of their
respective dates. No executive officer of the Company or any
Company Subsidiary has failed in any respect to make the
certifications required of him or her under Section 302 or 906 of
the Sarbanes-Oxley Act of 2002.
(ii) The records,
systems, controls, data and information of the Company and the
Company Subsidiaries are recorded, stored, maintained and operated
under means (including any electronic, mechanical or photographic
process, whether computerized or
not) that are under the exclusive ownership and direct control
of the Company or the Company Subsidiaries or their accountants
(including all means of access thereto and therefrom), except for
any non-exclusive ownership and non-direct control that would not
reasonably be expected to have a material adverse effect on the
system of internal accounting controls described below in this
Section 2.2(i)(ii). The Company (A) has implemented and maintains
disclosure controls and procedures (as defined in Rule 13a-15(e) of
the Exchange Act) to ensure that material information relating to
the Company, including the consolidated Company Subsidiaries, is
made known to the chief executive officer and the chief financial
officer of the Company by others within those entities, and (B) has
disclosed, based on its most recent evaluation prior to the Signing
Date, to the Company’s outside auditors and the audit
committee of the Board of Directors (x) any significant
deficiencies and material weaknesses in the design or operation of
internal controls over financial reporting (as defined in Rule
13a-15(f) of the Exchange Act) that are reasonably likely to
adversely affect the Company’s ability to record, process,
summarize and report financial information and (y) any fraud,
whether or not material, that involves management or other
employees who have a significant role in the Company’s
internal controls over financial reporting.
(j) No
Undisclosed Liabilities . Neither the Company nor any of the
Company Subsidiaries has any liabilities or obligations of any
nature (absolute, accrued, contingent or otherwise) which are not
properly reflected or reserved against in the Company Financial
Statements to the extent required to be so reflected or reserved
against in accordance with GAAP, except for (A) liabilities that
have arisen since the last fiscal year end in the ordinary and
usual course of business and consistent with past practice and (B)
liabilities that, individually or in the aggregate, have not had
and would not reasonably be expected to have a Company Material
Adverse Effect.
(k) Offering
of Securities. Neither the Company nor any person acting on its
behalf has taken any action (including any offering of any
securities of the Company under circumstances which would require
the integration of such offering with the offering of any of the
Purchased Securities under the Securities Act, and the rules and
regulations of the SEC promulgated thereunder), which might subject
the offering, issuance or sale of any of the Purchased Securities
to Investor pursuant to this Agreement to the registration
requirements of the Securities Act.
(1) Litigation and
Other Proceedings . Except (i) as set forth on Schedule
D or (ii) as would not, individually or in the aggregate,
reasonably be expected to have a Company Material Adverse Effect,
there is no (A) pending or, to the knowledge of the Company,
threatened, claim, action, suit, investigation or proceeding,
against the Company or any Company Subsidiary or to which any of
their assets are subject nor is the Company or any Company
Subsidiary subject to any order, judgment or decree or (B)
unresolved violation, criticism or exception by any Governmental
Entity with respect to any report or relating to any examinations
or inspections of the Company or any Company Subsidiaries.
(m) Compliance with
Laws . Except as would not, individually or in the aggregate
reasonably be expected to have a Company Material Adverse Effect,
the Company and the
Company Subsidiaries have all permits, licenses, franchises,
authorizations, orders and approvals of, and have made all filings,
applications and registrations with, Governmental Entities that are
required in order to permit them to own or lease their properties
and assets and to carry on their business as presently conducted
and that are material to the business of the Company or such
Company Subsidiary. Except as set forth on Schedule E , the
Company and the Company Subsidiaries have complied in all respects
and are not in default or violation of, and none of them is, to the
knowledge of the Company, under investigation with respect to or,
to the knowledge of the Company, have been threatened to be charged
with or given notice of any violation of, any applicable domestic
(federal, state or local) or foreign law, statute, ordinance,
license, rule, regulation, policy or guideline, order, demand,
writ, injunction, decree or judgment of any Governmental Entity,
other than such noncompliance, defaults or violations that would
not, individually or in the aggregate, reasonably be expected to
have a Company Material Adverse Effect. Except for statutory or
regulatory restrictions of general application or as set forth on
Schedule E , no Governmental Entity has placed any
restriction on the business or properties of the Company or any
Company Subsidiary that would, individually or in the aggregate,
reasonably be expected to have a Company Material Adverse
Effect.
(n) Employee
Benefit Matters . Except as would not reasonably be expected to
have, either individually or in the aggregate, a Company Material
Adverse Effect: (A) each "employee benefit plan" (within the
meaning of Section 3(3) of the Employee Retirement Income Security
Act of 1974, as amended ("ERISA")) providing benefits to any
current or former employee, officer or director of the Company or
any member of its "Controlled Group" (defined as any
organization which is a member of a controlled group of
corporations within the meaning of Section 414 of the Internal
Revenue Code of 1986, as amended (the "Code")) that is
sponsored, maintained or contributed to by the Company or any
member of its Controlled Group and for which the Company or any
member of its Controlled Group would have any liability, whether
actual or contingent (each, a "Plan") has been maintained in
compliance with its terms and with the requirements of all
applicable statutes, rules and regulations, including ERISA and the
Code; (B) with respect to each Plan subject to Title IV of ERISA
(including, for purposes of this clause (B), any plan subject to
Title IV of ERISA that the Company or any member of its Controlled
Group previously maintained or contributed to in the six years
prior to the Signing Date), (1) no "reportable event" (within the
meaning of Section 4043(c) of ERISA), other than a reportable event
for which the notice period referred to in Section 4043(c) of ERISA
has been waived, has occurred in the three years prior to the
Signing Date or is reasonably expected to occur, (2) no
"accumulated funding deficiency" (within the meaning of Section 302
of ERISA or Section 412 of the Code), whether or not waived, has
occurred in the three years prior to the Signing Date or is
reasonably expected to occur, (3) the fair market value of the
assets under each Plan exceeds the present value of all benefits
accrued under such Plan (determined based on the assumptions used
to fund such Plan) and (4) neither the Company nor any member of
its Controlled Group has incurred in the six years prior to the
Signing Date, or reasonably expects to incur, any liability under
Title IV of ERISA (other than contributions to the Plan or premiums
to the PBGC in the ordinary course and without default) in respect
of a Plan (including any Plan that is a "multiemployer plan",
within the meaning of Section 4001(c)(3) of ERISA); and (C) each
Plan that is intended to be qualified under Section 401(a) of the
Code has received a favorable determination letter from the
Internal Revenue Service with respect to its qualified status that
has not been revoked, or such a determination letter has been
timely applied for but not received by
the Signing Date, and nothing has occurred, whether by action or
by failure to act, which could reasonably be expected to cause the
loss, revocation or denial of such qualified status or favorable
determination letter.
(o) Taxes .
Except as would not, individually or in the aggregate, reasonably
be expected to have a Company Material Adverse Effect, (i) the
Company and the Company Subsidiaries have filed all federal, state,
local and foreign income and franchise Tax returns required to be
filed through the Signing Date, subject to permitted extensions,
and have paid all Taxes due thereon, and (ii) no Tax deficiency has
been determined adversely to the Company or any of the Company
Subsidiaries, nor does the Company have any knowledge of any Tax
deficiencies. "Tax" or "Taxes" means any federal,
state, local or foreign income, gross receipts, property, sales,
use, license, excise, franchise, employment, payroll, withholding,
alternative or add on minimum, ad valorem, transfer or excise tax,
or any other tax, custom, duty, governmental fee or other like
assessment or charge of any kind whatsoever, together with any
interest or penalty, imposed by any Governmental Entity.
(p) Properties and
Leases. Except as would not, individually or in the aggregate,
reasonably be expected to have a Company Material Adverse Effect,
the Company and the Company Subsidiaries have good and marketable
title to all real properties and all other properties and assets
owned by them, in each case free from liens, encumbrances, claims
and defects that would affect the value thereof or interfere with
the use made or to be made thereof by them. Except as would not,
individually or in the aggregate, reasonably be expected to have a
Company Material Adverse Effect, the Company and the Company
Subsidiaries hold all leased real or personal property under valid
and enforceable leases with no exceptions that would interfere with
the use made or to be made thereof by them.
(q) Environmental
Liability . Except as would not, individually or in the
aggregate, reasonably be expected to have a Company Material
Adverse Effect:
(i) there is no
legal, administrative, or other proceeding, claim or action of any
nature seeking to impose, or that would reasonably be expected to
result in the imposition of, on the Company or any Company
Subsidiary, any liability relating to the release of hazardous
substances as defined under any local, state or federal
environmental statute, regulation or ordinance, including the
Comprehensive Environmental Response, Compensation and Liability
Act of 1980, pending or, to the Company’s knowledge,
threatened against the Company or any Company Subsidiary;
(ii) to the
Company’s knowledge, there is no reasonable basis for any
such proceeding, claim or action; and
(iii) neither the Company nor
any Company Subsidiary is subject to any agreement, order, judgment
or decree by or with any court, Governmental Entity or third party
imposing any such environmental liability.
(r) Risk Management
Instruments . Except as would not, individually or in the
aggregate, reasonably be expected to have a Company Material
Adverse Effect, all derivative
instruments, including, swaps, caps, floors and option
agreements, whether entered into for the Company’s own
account, or for the account of one or more of the Company
Subsidiaries or its or their customers, were entered into (i) only
in the ordinary course of business, (ii) in accordance with prudent
practices and in all material respects with all applicable laws,
rules, regulations and regulatory policies and (iii) with
counterparties believed to be financially responsible at the time;
and each of such instruments constitutes the valid and legally
binding obligation of the Company or one of the Company
Subsidiaries, enforceable in accordance with its terms, except as
may be limited by the Bankruptcy Exceptions. Neither the Company or
the Company Subsidiaries, nor, to the knowledge of the Company, any
other party thereto, is in breach of any of its obligations under
any such agreement or arrangement other than such breaches that
would not, individually or in the aggregate, reasonably be expected
to have a Company Material Adverse Effect.
(s)
Agreements with Regulatory Agencies . Except as set forth on
Schedule F , neither the Company nor any Company Subsidiary
is subject to any material cease-and-desist or other similar order
or enforcement action issued by, or is a party to any material
written agreement, consent agreement or memorandum of understanding
with, or is a party to any commitment letter or similar undertaking
to, or is subject to any capital directive by, or since December
31, 2006, has adopted any board resolutions at the request of, any
Governmental Entity (other than the Appropriate Federal Banking
Agencies with jurisdiction over the Company and the Company
Subsidiaries) that currently restricts in any material respect the
conduct of its business or that in any material manner
relates to its capital adequacy, its liquidity and funding policies
and practices, its ability to pay dividends, its credit, risk
management or compliance policies or procedures, its internal
controls, its management or its operations or business (each item
in this sentence, a "Regulatory Agreement"), nor has the
Company or any Company Subsidiary been advised since December 31,
2006 by any such Governmental Entity that it is considering
issuing, initiating, ordering, or requesting any such Regulatory
Agreement. The Company and each Company Subsidiary are in
compliance in all material respects with each Regulatory Agreement
to which it is party or subject, and neither the Company nor any
Company Subsidiary has received any notice from any Governmental
Entity indicating that either the Company or any Company Subsidiary
is not in compliance in all material respects with any such
Regulatory Agreement. "Appropriate Federal Banking Agency"
means the "appropriate Federal banking agency" with respect to the
Company or such Company Subsidiaries, as applicable, as defined in
Section 3(q) of the Federal Deposit Insurance Act (12 U.S.C.
Section 1813(q)).
(t)
Insurance . The Company and the Company Subsidiaries are
insured with reputable insurers against such risks and in such
amounts as the management of the Company reasonably has determined
to be prudent and consistent with industry practice. The Company
and the Company Subsidiaries are in material compliance with their
insurance policies and are not in default under any of the material
terms thereof, each such policy is outstanding and in full force
and effect, all premiums and other payments due under any material
policy have been paid, and all claims thereunder have been filed in
due and timely fashion, except, in each case, as would not,
individually or in the aggregate, reasonably be expected to have a
Company Material Adverse Effect.
(u) Intellectual
Property . Except as would not, individually or in the
aggregate, reasonably be expected to have a Company Material
Adverse Effect, (i) the Company and each
Company Subsidiary owns or otherwise has the right to use, all
intellectual property rights, including all trademarks, trade
dress, trade names, service marks, domain names, patents,
inventions, trade secrets, know-how, works of authorship and
copyrights therein, that are used in the conduct of their existing
businesses and all rights relating to the plans, design and
specifications of any of its branch facilities ("Proprietary
Rights") free and clear of all liens and any claims of
ownership by current or former employees, contractors, designers or
others and (ii) neither the Company nor any of the Company
Subsidiaries is materially infringing, diluting, misappropriating
or violating, nor has the Company or any or the Company
Subsidiaries received any written (or, to the knowledge of the
Company, oral) communications alleging that any of them has
materially infringed, diluted, misappropriated or violated, any of
the Proprietary Rights owned by any other person. Except as would
not, individually or in the aggregate, reasonably be expected to
have a Company Material Adverse Effect, to the Company’s
knowledge, no other person is infringing, diluting,
misappropriating or violating, nor has the Company or any or the
Company Subsidiaries sent any written communications since January
1, 2006 alleging that any person has infringed, diluted,
misappropriated or violated, any of the Proprietary Rights owned by
the Company and the Company Subsidiaries.
(v) Brokers and
Finders . No broker, finder or investment banker is entitled to
any financial advisory, brokerage, finder’s or other fee or
commission in connection with this Agreement or the Warrant or the
transactions contemplated hereby or thereby based upon arrangements
made by or on behalf of the Company or any Company Subsidiary for
which the Investor could have any liability.
Article III
Covenants
|
|
3.1
|
Commercially Reasonable Efforts
.
|
(a) Subject to the
terms and conditions of this Agreement, each of the parties will
use its commercially reasonable efforts in good faith to take, or
cause to be taken, all actions, and to do, or cause to be done, all
things necessary, proper or desirable, or advisable under
applicable laws, so as to permit consummation of the Purchase as
promptly as practicable and otherwise to enable consummation of the
transactions contemplated hereby and shall use commercially
reasonable efforts to cooperate with the other party to that
end.
(b) If the Company is
required to obtain any stockholder approvals set forth on
Schedule C , then the Company shall comply with this Section
3.1(b) and Section 3
|